News
A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a ...
A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which ...
Tel Aviv University researchers say neutrophils can be late-stage breast cancer target and biomarker; Beilinson Hospital ...
ASCO Data Shows New Therapy Delays Breast Cancer Progression and May Improve Quality of Life for Women with Hormone ...
MUSC research to use he immune system to fight cancer shows it can be done safer, cheaper and better. An SC company pushing ...
Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...
The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...
Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical ...
Adding Roche's immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread ...
3d
SurvivorNet on MSNImmunotherapy For Small Cell Lung Cancer: Groundbreaking New Developments Offer Hope To PatientsFor the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...
Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...
Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results